ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Tr1X
The Research Associate II supports translational assay development and clinical sample analysis for ongoing and upcoming clinical trials. This role involves hands-on work with human blood and tissue specimens, performing flow cytometry, molecular assays, and cell-based assays to generate high-quality data. The position requires collaboration with scientists to optimize assays and maintain compliance with clinical sample handling protocols.
Tr1X is a clinical-stage biotechnology company engineering a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases. Leveraging cutting-edge genetic engineering and deep immunology expertise, Tr1X develops allogeneic, off-the-shelf Tr1/Treg cell therapies designed to restore immune tolerance and reset the immune system. The company has four active clinical programs spanning Crohn's disease, multiple sclerosis, graft-versus-host disease prevention following stem cell transplant, and autoimmune uveitis.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tr1X.
Scientist I/II, Pharmacology and Translational Science
Artiva Biotherapeutics
Associate Scientist (Cell Therapy)
Dawar Consulting
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Scientist I, Analytical Development
ImmunityBio
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Principal Biologist
Eli Lilly and Company